rs137853120
Variant summary
Our verdict is Pathogenic. Variant got 16 ACMG points: 16P and 0B. PM2PM5PP3_StrongPP5_Very_Strong
The NM_001374504.1(TMPRSS6):c.1534G>A(p.Asp512Asn) variant causes a missense change. The variant allele was found at a frequency of 0.000117 in 1,613,760 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. D512G) has been classified as Likely pathogenic.
Frequency
Consequence
NM_001374504.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 16 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TMPRSS6 | NM_001374504.1 | c.1534G>A | p.Asp512Asn | missense_variant | 13/18 | ENST00000676104.1 | NP_001361433.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TMPRSS6 | ENST00000676104.1 | c.1534G>A | p.Asp512Asn | missense_variant | 13/18 | NM_001374504.1 | ENSP00000501573 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000788 AC: 12AN: 152208Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000278 AC: 7AN: 251398Hom.: 0 AF XY: 0.0000147 AC XY: 2AN XY: 135880
GnomAD4 exome AF: 0.000121 AC: 177AN: 1461434Hom.: 0 Cov.: 32 AF XY: 0.000125 AC XY: 91AN XY: 727046
GnomAD4 genome AF: 0.0000788 AC: 12AN: 152326Hom.: 0 Cov.: 32 AF XY: 0.0000940 AC XY: 7AN XY: 74496
ClinVar
Submissions by phenotype
Iron-refractory iron deficiency anemia Pathogenic:3
Likely pathogenic, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Jul 24, 2021 | - - |
Pathogenic, no assertion criteria provided | literature only | OMIM | May 28, 2009 | - - |
Likely pathogenic, criteria provided, single submitter | curation | Broad Center for Mendelian Genomics, Broad Institute of MIT and Harvard | Jan 25, 2023 | The heterozygous p.Asp512Asn variant in TMPRSS6 was identified by our study, in the compound heterozygous state with a likely pathogenic variant (hg38 chr22:g.37098319_37127846del), in one individual with iron-refractory iron deficiency anemia. This individual also carried a likely pathogenic variant (hg38 chr22:g.37098319_37127846del), however the phase of these variants are unknown at this time. The p.Asp512Asn variant in TMPRSS6 has been previously reported in 2 unrelated individuals with iron-refractory iron deficiency anemia (PMID: 19357398, PMID: 18408718) and segregated with disease in 2 affected individuals in one family (PMID: 18408718), but has been identified in 0.006% (8/129158) of non-Finnish European chromosomes by the Genome Aggregation Database (gnomAD, http://gnomad.broadinstitute.org; dbSNP ID: rs137853120). Although this variant has been seen in the general population in a heterozygous state, its frequency is low enough to be consistent with a recessive carrier frequency. This variant has also been reported in ClinVar (Variation ID: 1404) and has been interpreted as pathogenic by OMIM and as likely pathogenic by Knight Diagnostic Laboratories, Oregon Health and Sciences University. Of the two unrelated individuals previously reported (PMID: 19357398, PMID: 18408718), one was a compound heterozygote that carried a reported pathogenic/likely pathogenic variant in trans (PMID: 18408718, ClinVar Variation ID: 1403) and the other was a compound heterozygote that carried a variant of uncertain significance in trans (PMID: 19357398, ClinVar Variation ID: 39759), which increases the likelihood that the p.Asp512Asn variant is pathogenic. The p.Asp512Asn variant is located in the LDLR domain, which may mediate interactions of the protein with macromolecules such as serine protease:inhibitor complexes and lipoproteins (PMID: 17981570), and multiple variants in the same region as p.Asp512Asn variant have been reported in association with disease in ClinVar (Variation ID: 30802, 1299579), suggesting that this variant is in a mutational hotspot and key functional domain and slightly supports pathogenicity. In vitro functional studies provide some evidence that the p.Asp512Asn variant may slightly impact protein function (PMID: 19357398). However, these types of assays may not accurately represent biological function. Computational prediction tools and conservation analyses suggest that this variant may impact the protein, though this information is not predictive enough to determine pathogenicity. In summary, although additional studies are required to fully establish its clinical significance, this variant is likely pathogenic for autosomal recessive iron-refractory iron deficiency anemia. ACMG/AMP Criteria applied: PS3_Supporting, PM1_Supporting, PM2_Supporting, PM3, PP3 (Richards 2015). - |
Microcytic anemia Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Knight Diagnostic Laboratories, Oregon Health and Sciences University | Jun 01, 2017 | - - |
TMPRSS6-related disorder Pathogenic:1
Pathogenic, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Aug 01, 2024 | The TMPRSS6 c.1561G>A variant is predicted to result in the amino acid substitution p.Asp521Asn. This variant has been reported in two compound heterozygous individuals with iron-refractory iron deficiency anemia (IRIDA) (Finberg et al. 2008. PubMed ID: 18408718; Silvestri et al. 2009. PubMed ID: 19357398). Functional studies have shown the c.1561G>A (p.Asp521Asn) variant to result in intracellular retention of the TMPRSS6 protein (Silvestri et al. 2009. PubMed ID: 19357398). This variant is reported in 0.0062% of alleles in individuals of European (Non-Finnish) descent in gnomAD. This variant is interpreted as pathogenic. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at